Answers are grounded in this paper and cite their sources.
Rosa rugosa hips are a valuable resource rich in flavonoids with significant health benefits, though the regulatory mechanisms underlying flavonoid biosynthesis remain unclear. In R. rugosa hip, the chlorophyll content decreased significantly during hip ripening from the green (F0) to the yellow (F1) and red (F2) stages. In contrast, total flavonoid content peaked at the F1 stage, while anthocyanin and carotenoid levels showed a concomitant increase. To investigate the regulatory mechanisms, we performed integrated transcriptomic and metabolomic analyses of wild R. rugosa hips at the F1 and F2 stages. Transcriptomic data revealed 4,329 DEGs, which were predominantly enriched in 'Metabolic pathways' and 'Biosynthesis of secondary metabolites' by KEGG pathway enrichment analysis. Notably, 62 upregulated DEGs were assigned to specific flavonoid-related biosynthesis pathways. Meanwhile, metabolomic profiling identified 729 flavonoids, 308 of which were differentially accumulated metabolites (DAMs). Importantly, anthocyanin content increased upon ripening, while most other flavonoids decreased. Association analysis highlighted critical genes in anthocyanin biosynthesis, including upregulated BZ1, AOMT, 3MaT1, and 3MaT2, which correlated with the accumulation of specific derivatives like cyanidin 3-O-(6-O27 malonyl)-β-D-glucoside and peonidin 3-glucoside, contributing to the hip's red color. Similarly, CYP81E genes were linked to isoflavonoid accumulation, while downregulated CYP75B1 genes corresponded to decreased quercetin levels. These findings systematically elucidate the transcriptional and metabolic landscape of flavonoid biosynthesis during R. rugosa hip ripening, providing crucial insights for future genetic engineering aimed at enhancing flavonoid content and hip quality.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: